Insmed Incorporated Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $14.2 Billion | 2/18 | BGNE $20.2B |
INSM $14.2B |
CERE $8.2B |
RVMD $7.6B |
ASND $7.5B |
HALO $7.4B |
BPMC $6.6B |
SWTX $4.1B |
RARE $4.0B |
RNA $3.8B |
APLS $3.5B |
EWTX $2.4B |
HRMY $2.2B |
JANX $2.1B |
AGIO $1.9B |
DAWN $1.2B |
KROS $413.2M |
FENC $178.8M |
Gross Margin | 77% | 14/18 | KROS 100% |
RNA 100% |
JANX 100% |
BPMC 98% |
SWTX 93% |
DAWN 92% |
AGIO 91% |
RARE 85% |
HALO 83% |
BGNE 83% |
APLS 81% |
ASND 81% |
FENC 81% |
INSM 77% |
HRMY 77% |
RVMD 0% |
CERE 0% |
EWTX 0% |
Profit Margin | -100% | 13/18 | AGIO 100% |
DAWN 100% |
HALO 47% |
HRMY 25% |
RVMD 0% |
CERE 0% |
EWTX 0% |
BGNE -12% |
APLS -33% |
BPMC -44% |
FENC -82% |
RARE -96% |
INSM -100% |
ASND -100% |
SWTX -100% |
KROS -100% |
RNA -100% |
JANX -100% |
EBITDA margin | -228% | 14/18 | DAWN 148% |
HALO 56% |
HRMY 39% |
BGNE -5% |
BPMC -26% |
APLS -38% |
FENC -67% |
RARE -95% |
RVMD -100% |
CERE -100% |
EWTX -100% |
SWTX -118% |
ASND -123% |
INSM -228% |
AGIO -1147% |
RNA -4171% |
JANX -8164% |
KROS -15118% |
Quarterly Revenue | $93.4 Million | 7/18 | BGNE $1.0B |
HALO $290.1M |
HRMY $186.0M |
APLS $176.6M |
RARE $139.5M |
BPMC $128.2M |
INSM $93.4M |
ASND $63.6M |
SWTX $49.3M |
DAWN $20.1M |
AGIO $9.0M |
FENC $7.0M |
RNA $2.3M |
JANX $439,000 |
KROS $388,000 |
RVMD $0 |
CERE $0 |
EWTX $0 |
Quarterly Earnings | -$220.5 Million | 18/18 | AGIO $947.9M |
HALO $137.0M |
HRMY $46.1M |
DAWN $37.0M |
FENC -$5.7M |
JANX -$28.1M |
EWTX -$34.1M |
KROS -$53.0M |
SWTX -$53.5M |
BPMC -$56.3M |
APLS -$57.4M |
RNA -$80.4M |
ASND -$109.0M |
BGNE -$121.4M |
CERE -$131.9M |
RARE -$133.5M |
RVMD -$156.3M |
INSM -$220.5M |
Quarterly Free Cash Flow | -$184.6 Million | 17/18 | HALO $113.9M |
HRMY $70.5M |
BGNE $54.7M |
APLS $34.1M |
FENC -$2.2M |
JANX -$2.3M |
DAWN -$5.0M |
BPMC -$13.7M |
SWTX -$16.0M |
EWTX -$27.9M |
KROS -$30.9M |
RARE -$56.1M |
RNA -$67.3M |
AGIO -$84.6M |
CERE -$119.9M |
RVMD -$133.9M |
INSM -$184.6M |
ASND -$0 |
Trailing 4 Quarters Revenue | $343.0 Million | 8/18 | BGNE $3.3B |
HALO $947.4M |
HRMY $681.9M |
APLS $675.9M |
RARE $522.7M |
BPMC $434.4M |
ASND $360.0M |
INSM $343.0M |
SWTX $135.5M |
FENC $49.6M |
AGIO $32.9M |
DAWN $28.8M |
JANX $13.0M |
RNA $10.1M |
KROS $651,000 |
RVMD $0 |
CERE $0 |
EWTX $0 |
Trailing 4 Quarters Earnings | -$864.3 Million | 18/18 | BGNE $1.0B |
HALO $290.1M |
HRMY $186.0M |
APLS $176.6M |
RARE $139.5M |
BPMC $128.2M |
INSM $93.4M |
ASND $63.6M |
SWTX $49.3M |
DAWN $20.1M |
AGIO $9.0M |
FENC $7.0M |
RNA $2.3M |
JANX $439,000 |
KROS $388,000 |
RVMD -$0 |
CERE -$0 |
EWTX -$0 |
Quarterly Earnings Growth | -39% | 14/18 | AGIO 1138% |
DAWN 180% |
HALO 67% |
APLS 59% |
BPMC 58% |
ASND 39% |
SWTX 33% |
HRMY 20% |
RARE 16% |
RVMD 9% |
CERE -26% |
EWTX -33% |
KROS -34% |
INSM -39% |
RNA -54% |
JANX -143% |
BGNE -156% |
FENC -207% |
Annual Earnings Growth | 3% | 12/18 | AGIO 297% |
FENC 93% |
BPMC 76% |
APLS 51% |
DAWN 50% |
HALO 28% |
ASND 19% |
RARE 13% |
SWTX 12% |
BGNE 7% |
JANX 6% |
INSM 3% |
HRMY 1% |
RVMD -16% |
KROS -19% |
CERE -20% |
EWTX -38% |
RNA -45% |
Quarterly Revenue Growth | 18% | 10/18 | KROS 4750% |
SWTX 783% |
BPMC 127% |
APLS 78% |
RARE 42% |
HALO 34% |
BGNE 28% |
AGIO 21% |
ASND 20% |
INSM 18% |
HRMY 16% |
FENC 7% |
CERE 0% |
EWTX 0% |
DAWN 0% |
RNA -17% |
JANX -83% |
RVMD -100% |
Annual Revenue Growth | 10% | 12/18 | KROS 8038% |
SWTX 487% |
FENC 201% |
JANX 129% |
BPMC 89% |
APLS 76% |
ASND 72% |
BGNE 29% |
RARE 24% |
HRMY 21% |
AGIO 19% |
INSM 10% |
HALO 8% |
RNA 4% |
CERE 0% |
EWTX 0% |
DAWN 0% |
RVMD -100% |
Cash On Hand | $461.5 Million | 4/18 | BGNE $2.7B |
ASND $687.4M |
KROS $530.7M |
INSM $461.5M |
DAWN $422.8M |
APLS $396.9M |
HRMY $387.4M |
RNA $370.2M |
CERE $320.4M |
AGIO $253.7M |
RVMD $201.3M |
HALO $154.3M |
RARE $150.6M |
BPMC $89.4M |
SWTX $84.5M |
EWTX $44.8M |
FENC $40.3M |
JANX $26.8M |
Short Term Debt | $10.5 Million | 6/18 | BGNE $881.5M |
ASND $494.2M |
BPMC $45.0M |
AGIO $16.3M |
HRMY $15.0M |
INSM $10.5M |
RARE $10.4M |
RVMD $8.4M |
APLS $6.8M |
RNA $3.8M |
CERE $3.5M |
KROS $1.9M |
JANX $1.7M |
SWTX $1.2M |
EWTX $992,000 |
DAWN $77,000 |
FENC $7,000 |
HALO -$0 |
Long Term Debt | $989.4 Million | 2/18 | HALO $1.5B |
INSM $989.4M |
RARE $829.7M |
ASND $372.5M |
CERE $364.8M |
BPMC $341.5M |
BGNE $220.0M |
HRMY $167.8M |
APLS $104.7M |
RVMD $78.3M |
AGIO $44.5M |
JANX $43.5M |
KROS $17.4M |
SWTX $5.7M |
RNA $3.8M |
EWTX $3.4M |
DAWN $2.5M |
FENC $0 |
PE | -1.00 | 4/18 | HALO 18.84 |
HRMY 15.11 |
AGIO 2.77 |
INSM -1.00 |
BGNE -1.00 |
RARE -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
FENC -1.00 |
RVMD -1.00 |
SWTX -1.00 |
KROS -1.00 |
RNA -1.00 |
CERE -1.00 |
EWTX -1.00 |
DAWN -1.00 |
JANX -1.00 |
PS | 41.52 | 6/18 | KROS 634.68 |
RNA 375.37 |
JANX 162.91 |
AGIO 56.92 |
DAWN 42.44 |
INSM 41.52 |
SWTX 30.27 |
ASND 19.05 |
BPMC 15.14 |
HALO 7.80 |
RARE 7.67 |
BGNE 6.09 |
APLS 5.25 |
FENC 3.60 |
HRMY 3.16 |
RVMD -1.00 |
CERE -1.00 |
EWTX -1.00 |
PB | 29.46 | 1/18 | INSM 29.46 |
BPMC 21.01 |
HALO 16.33 |
APLS 14.96 |
CERE 14.51 |
RARE 11.33 |
SWTX 7.70 |
BGNE 5.88 |
EWTX 5.01 |
RVMD 4.83 |
HRMY 3.62 |
JANX 3.24 |
RNA 2.53 |
DAWN 2.20 |
AGIO 1.15 |
KROS 0.78 |
ASND 0.00 |
FENC 0.00 |
PC | 30.86 | 7/18 | JANX 79.46 |
BPMC 73.62 |
EWTX 54.63 |
SWTX 48.56 |
HALO 47.91 |
RVMD 37.56 |
INSM 30.86 |
RARE 26.63 |
CERE 25.56 |
ASND 10.97 |
RNA 10.26 |
APLS 8.94 |
BGNE 7.48 |
AGIO 7.37 |
HRMY 5.57 |
FENC 4.44 |
DAWN 2.89 |
KROS 0.78 |
Liabilities to Equity | 3.25 | 3/18 | HALO 3.68 |
RARE 3.42 |
INSM 3.25 |
BPMC 2.83 |
APLS 2.80 |
CERE 1.00 |
BGNE 0.70 |
HRMY 0.56 |
SWTX 0.14 |
RVMD 0.13 |
AGIO 0.10 |
KROS 0.09 |
RNA 0.09 |
DAWN 0.08 |
JANX 0.06 |
EWTX 0.05 |
ASND 0.00 |
FENC 0.00 |
ROA | -0.42 | 16/18 | AGIO 38% | HALO 19% | HRMY 15% | FENC -2% | JANX -9% | BPMC -11% | BGNE -15% | DAWN -15% | RNA -17% | EWTX -24% | APLS -28% | RVMD -31% | KROS -31% | RARE -36% | CERE -41% | INSM -42% | ASND -43% | SWTX -45% |
ROE | -1.79 | 18/18 | ASND 482% |
HALO 87% |
AGIO 41% |
HRMY 24% |
FENC 23% |
JANX -9% |
DAWN -16% |
RNA -19% |
BGNE -25% |
EWTX -25% |
RVMD -34% |
KROS -34% |
BPMC -41% |
SWTX -52% |
CERE -82% |
APLS -105% |
RARE -161% |
INSM -179% |
Current Ratio | 1.31 | 14/18 | EWTX 22.82 |
JANX 17.86 |
DAWN 13.25 |
KROS 12.47 |
RNA 11.94 |
AGIO 10.85 |
RVMD 8.96 |
SWTX 7.98 |
HRMY 2.80 |
BGNE 2.43 |
CERE 2.00 |
APLS 1.36 |
BPMC 1.35 |
INSM 1.31 |
RARE 1.30 |
HALO 1.27 |
ASND 0.92 |
FENC 0.92 |
Quick Ratio | 0.94 | 12/18 | HALO 18.84 |
HRMY 15.11 |
AGIO 2.77 |
INSM -1.00 |
BGNE -1.00 |
RARE -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
FENC -1.00 |
RVMD -1.00 |
SWTX -1.00 |
KROS -1.00 |
RNA -1.00 |
CERE -1.00 |
EWTX -1.00 |
DAWN -1.00 |
JANX -1.00 |
Long Term Debt to Equity | 2.05 | 3/18 | HALO} 3.32 |
RARE} 2.39 |
INSM} 2.05 |
BPMC} 1.09 |
CERE} 0.65 |
APLS} 0.44 |
HRMY} 0.28 |
JANX} 0.07 |
BGNE} 0.06 |
RVMD} 0.05 |
AGIO} 0.03 |
KROS} 0.03 |
SWTX} 0.01 |
EWTX} 0.01 |
FENC} 0.00 |
RNA} 0.00 |
DAWN} 0.00 |
ASND} -3.48 |
Debt to Equity | 2.07 | 2/18 | HALO 3.32 |
INSM 2.07 |
BPMC 1.23 |
CERE 0.65 |
APLS 0.47 |
BGNE 0.32 |
HRMY 0.31 |
RVMD 0.06 |
AGIO 0.04 |
KROS 0.04 |
JANX 0.04 |
RARE 0.03 |
SWTX 0.01 |
RNA 0.01 |
EWTX 0.01 |
FENC 0.00 |
DAWN 0.00 |
ASND -8.10 |
Burn Rate | 1.76 | 8/18 | KROS 9.81 |
BGNE 7.71 |
FENC 7.03 |
APLS 6.27 |
RNA 4.54 |
ASND 2.66 |
CERE 2.17 |
INSM 1.76 |
SWTX 1.56 |
EWTX 1.30 |
RVMD 1.25 |
BPMC 1.10 |
RARE 0.89 |
JANX 0.89 |
AGIO -0.27 |
HALO -2.01 |
HRMY -10.87 |
DAWN -11.45 |
Cash to Cap | 0.03 | 12/18 | KROS 1.28 |
DAWN 0.35 |
FENC 0.23 |
HRMY 0.18 |
AGIO 0.14 |
BGNE 0.13 |
APLS 0.11 |
RNA 0.10 |
ASND 0.09 |
RARE 0.04 |
CERE 0.04 |
INSM 0.03 |
RVMD 0.03 |
HALO 0.02 |
SWTX 0.02 |
EWTX 0.02 |
BPMC 0.01 |
JANX 0.01 |
CCR | 0.84 | 4/18 | HRMY 1.53 |
CERE 0.91 |
RVMD 0.86 |
INSM 0.84 |
RNA 0.84 |
HALO 0.83 |
EWTX 0.82 |
KROS 0.58 |
RARE 0.42 |
FENC 0.38 |
SWTX 0.30 |
BPMC 0.24 |
JANX 0.08 |
AGIO -0.09 |
DAWN -0.13 |
BGNE -0.45 |
APLS -0.59 |
ASND |
EV to EBITDA | -69.25 | 14/18 | HALO} 53.57 |
DAWN} 27.10 |
HRMY} 26.95 |
KROS} 1.67 |
RVMD} -1.00 |
CERE} -1.00 |
EWTX} -1.00 |
AGIO} -16.32 |
RARE} -29.32 |
FENC} -29.57 |
RNA} -35.26 |
APLS} -48.28 |
JANX} -59.22 |
INSM} -69.25 |
SWTX} -69.44 |
ASND} -118.75 |
BPMC} -206.03 |
BGNE} -379.98 |
EV to Revenue | 43.09 | 4/18 | RNA 339.53 |
JANX 162.66 |
AGIO 51.06 |
INSM 43.09 |
SWTX 29.70 |
DAWN 27.86 |
ASND 23.46 |
BPMC 15.83 |
HALO 9.23 |
RARE 7.40 |
BGNE 5.61 |
APLS 4.82 |
HRMY 2.86 |
FENC 2.79 |
RVMD -1.00 |
CERE -1.00 |
EWTX -1.00 |
KROS -150.88 |